Sanofi Teams With US Military On Zika, But Not For The Profits
Sanofi Pasteur has entered into an agreement with the US Walter Reed Army Institute of Research, part of the Department of Defense, to develop a Zika vaccine. But the company said it's not doing it for any potential profits, but has a "moral imperative" to respond to the epidemic.
You may also be interested in...
Nothing's even in Phase II yet, but sponsors and US government researchers remain optimistic.
FDA and NIH officials propose three strategies for clinical trials, saying it will be challenging to identify the most promising candidates; Sanofi and Walter Reed researchers note challenges in vaccine development, including manufacturing scale up.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.